These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11195553)

  • 1. A therapeutic approach to children and adolescents with anxiety disorders and associated comorbid conditions.
    Manassis K; Monga S
    J Am Acad Child Adolesc Psychiatry; 2001 Jan; 40(1):115-7. PubMed ID: 11195553
    [No Abstract]   [Full Text] [Related]  

  • 2. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature of anxiety comorbid with attention deficit hyperactivity disorder in children from a pediatric primary care setting.
    Bowen R; Chavira DA; Bailey K; Stein MT; Stein MB
    Psychiatry Res; 2008 Jan; 157(1-3):201-9. PubMed ID: 18023880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four-year follow-up study of children with ADHD.
    Biederman J; Faraone SV; Milberger S; Jetton JG; Chen L; Mick E; Greene RW; Russell RL
    J Am Acad Child Adolesc Psychiatry; 1996 Sep; 35(9):1193-204. PubMed ID: 8824063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity of attention-deficit hyperactivity disorder and overanxious disorder.
    Pliszka SR
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):197-203. PubMed ID: 1564019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multimodal treatment concepts in children and adolescents with attention deficit/hyperactive disorder].
    Lehmkuhl G
    MMW Fortschr Med; 2005 Dec; 147(48):32-4, 36. PubMed ID: 16389859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADHD and comorbidity in childhood.
    Spencer TJ
    J Clin Psychiatry; 2006; 67 Suppl 8():27-31. PubMed ID: 16961427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of diagnostic comorbidity in a community sample of children aged 9 through 16 years.
    Bird HR; Gould MS; Staghezza BM
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):361-8. PubMed ID: 8444766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopathology among offspring of parents with substance abuse and/or anxiety disorders: a high-risk study.
    Merikangas KR; Dierker LC; Szatmari P
    J Child Psychol Psychiatry; 1998 Jul; 39(5):711-20. PubMed ID: 9690934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oppositional defiant disorder with onset in preschool years: longitudinal stability and pathways to other disorders.
    Lavigne JV; Cicchetti C; Gibbons RD; Binns HJ; Larsen L; DeVito C
    J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1393-400. PubMed ID: 11765284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A naturalistic exploratory study of the impact of demographic, phenotypic and comorbid features in pediatric obsessive-compulsive disorder.
    Masi G; Millepiedi S; Perugi G; Pfanner C; Berloffa S; Pari C; Mucci M; Akiskal HS
    Psychopathology; 2010; 43(2):69-78. PubMed ID: 20068377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the association between pediatric bipolar disorder and anxiety disorders in psychiatrically referred children and adolescents.
    Harpold TL; Wozniak J; Kwon A; Gilbert J; Wood J; Smith L; Biederman J
    J Affect Disord; 2005 Sep; 88(1):19-26. PubMed ID: 16043229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention deficit hyperactivity disorder. Epidemiologic, pathophysiologic, diagnostic and treatment perspectives.
    Al-Ghamdy YS; Qureshi NA
    Saudi Med J; 2001 Aug; 22(8):666-73. PubMed ID: 11573110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood psychopathology and adolescent cigarette smoking: a prospective survival analysis in children at high risk for substance use disorders.
    Clark DB; Cornelius J
    Addict Behav; 2004 Jun; 29(4):837-41. PubMed ID: 15135569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base.
    Hall W; Degenhardt L; Teesson M
    Addict Behav; 2009; 34(6-7):526-30. PubMed ID: 19386422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity as a predictor and moderator of treatment outcome in youth with anxiety, affective, attention deficit/hyperactivity disorder, and oppositional/conduct disorders.
    Ollendick TH; Jarrett MA; Grills-Taquechel AE; Hovey LD; Wolff JC
    Clin Psychol Rev; 2008 Dec; 28(8):1447-71. PubMed ID: 18973971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.
    Pliszka SR
    J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and correlates of asthma in children with internalizing psychopathology.
    Meuret AE; Ehrenreich JT; Pincus DB; Ritz T
    Depress Anxiety; 2006; 23(8):502-8. PubMed ID: 16841339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and research implications of panic-bipolar comorbidity in children and adolescents.
    Masi G; Perugi G; Millepiedi S; Toni C; Mucci M; Bertini N; Pfanner C; Berloffa S; Pari C; Akiskal K; Akiskal HS
    Psychiatry Res; 2007 Sep; 153(1):47-54. PubMed ID: 17602754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood attention deficit hyperactivity disorder and the development of substance use disorders: valid concern or exaggeration?
    Looby A
    Addict Behav; 2008 Mar; 33(3):451-63. PubMed ID: 18037571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.